Literature DB >> 7934150

Cystic fibrosis.

M R Bye1, J M Ewig, L M Quittell.   

Abstract

While the care of cystic fibrosis (CF) patients has been mainly the province of pediatricians, great improvements in the therapy and life span of CF patients often results in their transition to care by adult physicians. In this review of CF, we begin with an overview of the epidemiology and genetics of the disease, with a discussion of the recently found ion abnormalities that lead to the clinical manifestations. This is followed by a discussion of the pathophysiology. Methods of diagnosis, ranging from the gold standard, the sweat test, to recent advances based on a greater understanding of the genetics of the disease are reviewed. This is followed by a discussion of therapy primarily geared to the treatment of the respiratory complications, as they are the most common lethal factors of the disease. We point out controversies where they exist. Newer forms of therapy such as lung transplantation are discussed, and we finish with a discussion about future therapeutic modalities, some of which are being approved as the paper is in print.

Entities:  

Mesh:

Year:  1994        PMID: 7934150     DOI: 10.1007/bf00164308

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  143 in total

1.  Hepatic cirrhosis associated with fibrocystic disease of the pancreas; clinical and pathological reports of five patients.

Authors:  R WEBSTER; H WILLIAMS
Journal:  Arch Dis Child       Date:  1953-10       Impact factor: 3.791

2.  The American Society of Human Genetics statement on cystic fibrosis screening.

Authors:  C T Caskey; M M Kaback; A L Beaudet
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

Review 3.  Genetic counseling using linked DNA probes: cystic fibrosis as a prototype.

Authors:  J P Johnson
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

Review 4.  Meconium in health and in disease.

Authors:  I Antonowicz; H Shwachman
Journal:  Adv Pediatr       Date:  1979

Review 5.  The cardiovascular system in cystic fibrosis.

Authors:  A J Moss
Journal:  Pediatrics       Date:  1982-11       Impact factor: 7.124

6.  Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions?

Authors:  J R Bateman; S P Newman; K M Daunt; N F Sheahan; D Pavia; S W Clarke
Journal:  Thorax       Date:  1981-09       Impact factor: 9.139

7.  Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study.

Authors:  W B Wheeler; M Williams; W J Matthews; H R Colten
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

8.  Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis.

Authors:  M J Coffey; M X FitzGerald; W T McNicholas
Journal:  Chest       Date:  1991-09       Impact factor: 9.410

9.  Insulin receptors in cystic fibrosis: increased receptor number and altered affinity.

Authors:  B M Lippe; S A Kaplan; N D Neufeld; A Smith; M Scott
Journal:  Pediatrics       Date:  1980-05       Impact factor: 7.124

10.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

View more
  5 in total

Review 1.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

2.  Carbon Sources Tune Antibiotic Susceptibility in Pseudomonas aeruginosa via Tricarboxylic Acid Cycle Control.

Authors:  Sylvain Meylan; Caroline B M Porter; Jason H Yang; Peter Belenky; Arnaud Gutierrez; Michael A Lobritz; Jihye Park; Sun H Kim; Samuel M Moskowitz; James J Collins
Journal:  Cell Chem Biol       Date:  2017-01-19       Impact factor: 8.116

Review 3.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

4.  Modulation of epithelial sodium channel (ENaC) expression in mouse lung infected with Pseudomonas aeruginosa.

Authors:  André Dagenais; Diane Gosselin; Claudine Guilbault; Danuta Radzioch; Yves Berthiaume
Journal:  Respir Res       Date:  2005-01-06

Review 5.  Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.

Authors:  Simona Barone; Emilia Cassese; Antonella Ilenia Alfano; Margherita Brindisi; Vincenzo Summa
Journal:  J Med Chem       Date:  2022-02-11       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.